We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current UTHR market cap is 14.35B. The company's latest EPS is USD 26.6097 and P/E is 11.95.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 614.7M | 677.7M | 714.9M | 748.9M | 735.9M |
| Operating Income | 260.1M | 356.3M | 319.9M | 237.2M | 357.7M |
| Net Income | 217.1M | 306.6M | 278.1M | 309.1M | 301.3M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.48B | 1.69B | 1.94B | 2.33B | 2.88B |
| Operating Income | 593.6M | 442.5M | 979.7M | 1.18B | 1.38B |
| Net Income | 514.8M | 362.4M | 727.3M | 984.8M | 1.2B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.17B | 6.5B | 6.72B | 7.12B | 7.36B |
| Total Liabilities | 1.18B | 1.16B | 1.03B | 1.02B | 920M |
| Total Equity | 5.98B | 5.34B | 5.7B | 6.1B | 6.44B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.62B | 5.17B | 6.04B | 7.17B | 7.36B |
| Total Liabilities | 1.22B | 1.21B | 1.25B | 1.18B | 920M |
| Total Equity | 3.4B | 3.96B | 4.8B | 5.98B | 6.44B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 978M | 376.5M | 608.7M | 985.9M | 1.33B |
| Investing | -719.6M | 735.3M | 655.3M | 540.4M | 417.2M |
| Financing | -11.9M | -1.07B | -1.12B | -1.18B | -1.25B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 755.7M | 598.2M | 802.5M | 978M | 1.33B |
| Investing | -738.5M | -486.9M | -811.5M | -719.6M | 417.2M |
| Financing | -16.9M | 44.8M | 75.4M | -11.9M | -1.25B |
| Market Cap | 14.35B |
| Price to Earnings Ratio | 11.95 |
| Price to Sales Ratio | 4.96 |
| Price to Cash Ratio | 8.41 |
| Price to Book Ratio | 2.22 |
| Dividend Yield | - |
| Shares Outstanding | 44.91M |
| Average Volume (1 week) | 544.94k |
| Average Volume (1 Month) | 624.01k |
| 52 Week Change | 30.72% |
| 52 Week High | 417.815 |
| 52 Week Low | 221.53 |
| Spread (Intraday) | 30.91 (9.48%) |
| Company Name | United Therapeutics Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.unither.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
